The study on the Global Adipose-Derived Stem Cell Market is the latest report covering the impact analysis of the currently ongoing COVID-19 pandemic. The pandemic has directly affected the market by causing disruptions in the global supply chains and indirectly by inducing financial difficulties. The Adipose-Derived Stem Cell market has witnessed dynamic changes in trends and demands owing to the ongoing COVID-19 pandemic. The report provides a detailed outlook on how the pandemic has affected the key segments of the Adipose-Derived Stem Cell industry. The report includes an in-depth impact analysis of the COVID-19 pandemic on the overall Adipose-Derived Stem Cell industry. The report contains unbiased industry expert opinions on the current market scenario, past market performance, production & consumption rates, demand & supply ratio, and revenue generation forecasts over the estimated period.

Exhaustive coverage of the COVID-19 impact on the Adipose-Derived Stem Cell industry is a major attraction of the report. The global health emergency has beleaguered the global economy, thereby disrupting this particular business domain’s functioning mechanism. It assesses the present market scenario and forecasts the pandemic’s aftermath in this business sector to help organizations boost their COVID-19

Get a sample of the report :

Market Scope:

One of the report’s central components is the broad Adipose-Derived Stem Cell market segmentation that includes the product type gamut, application spectrum, end-user industry landscape, significant geographical regions, and the top market contenders. The key players’ financial positions, along with their gross profits, sales volumes, sales revenue, manufacturing costs, and other financial ratios, have been accurately gauged in the report. Furthermore, several analytical tools like investment assessment, SWOT analysis, and Porter’s Five Forces Analysis have been implemented by our analysts’ team to evaluate the production and distribution capacities of the Adipose-Derived Stem Cell market players.

ASCs can be harvested in large number from adipose tissues by a minimally invasive procedure, thereby increasing their potential for regenerating tissues and organs damaged by severe injury or chronic diseases. ASCs are widely used for cell-based therapy and in combination with biomaterials or drugs to accelerate the treatment process. ASCs also show great potential in wound healing and also have immunomodulatory effects. A large number of clinical trials are ongoing across the globe to explore the potential of adipose-derived stem cells in regenerative medicine and tissue engineering and this is also expected to drive revenue growth over the forecast period.

Some Key Highlights in the Report:

Allogenic stem cells segment to account for largest revenue share in the global market over the forecast period owing to increasing application of allogenic stem cells in various cell-based therapies and rising availability of stem cell therapy products based on allogenic stem cells.

Musculoskeletal diseases segment is expected to register significant revenue growth over the forecast period owing to increasing prevalence of musculoskeletal disorders and increasing application of regenerative medicine to treat bone and joint diseases.

Research application segment is expected to register robust revenue CAGR over the forecast period owing to increasing investment and funding to advance stem cell research and accelerate development of cell-based therapeutic products.

North America is expected to account for largest revenue share between 2021 and 2028 owing to rising private and public funding, increasing number of research activities, financial support from government to accelerate stem cell research, increasing incidence of musculoskeletal and bone and joint disorders, and presence of key players in the region.

Key companies in the market include Allocure, Inc., Celgene Corporation, Pluristem Therapeutics, Inc., Intrexon, Inc., Celleris SA, Tissue Genesis, Inc., Mesoblast, Ltd., Antaria, Inc. Thermo Fisher Scientific, Inc., American CryoStem, and Merck KGaA.

In September 2021, BioRestorative Therapies, Inc. announced that it had received a patent for its metabolic ThermoStem Program from the Australian Patient Office.

Request a discount on the report :

For the purpose of this report, Emergen Research has segmented the global adipose-derived stem cell market on the basis of cell type, product type, disease indication, end-use industries, application, and region:

Cell Type Outlook (Revenue, USD Billion; 2018–2028)

  • Allogenic
  • Autologous

Product Type Outlook (Revenue, USD Billion; 2018–2028)

  • Cell Line
  • Culture Media
  • Media
  • Sera
  • Reagents

Disease Indication Outlook (Revenue, USD Billion; 2018–2028)

  • Cancer
  • Obesity
  • Wounds & Injuries
  • Cardiovascular Diseases
  • Musculoskeletal

End-use Industries Outlook (Revenue, USD Billion; 2018–2028)

  • Cell Banks & Tissue Banks
  • Research Laboratories & Academic Institutes
  • Hospitals & Trauma Centers
  • Others

Application Outlook (Revenue, USD Billion; 2018–2028)

  • Therapeutic
  • Research

TOC of the global Adipose-Derived Stem Cell market report:

Chapter 1, describes the Adipose-Derived Stem Cell Introduction, market overview, product offerings, growth opportunities, market risks, driving forces, and challenges.

Chapter 2, analyzes the key manufacturers of Adipose-Derived Stem Cell , along with the sales, revenue, and price of Adipose-Derived Stem Cell , in the forecast period.

Chapter 3, studies the competitive situation among the major manufacturers and vendors, with sales, revenue, and market share.

Chapter 4, analyzes the global market by regions, with sales, revenue, and market share of Adipose-Derived Stem Cell , for each region, from 2020 to 2027.

Chapters 5, 6, 7, 8 and 9, analyze the Adipose-Derived Stem Cell market by type, application, regions, and manufacturers, with sales, revenue, and market share by key countries in these regions…Continued


Read More:

Related reports:

dental 3d printing market

face mask market

reproductive genetics market

oncolytic virus therapies market

usb flashdrives market

nanorobotics market

healthcare internet of things security market

About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research         and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756


Facebook | LinkdIn | Twitter | Blogs